Female sexual satisfaction and pharmaceutical intervention: A critical review of the drug intervention studies in female sexual dysfunction

被引:31
作者
Nijland, Esme
Davis, Susan
Laan, Ellen
Schultz, Willibrord Weijmar
机构
[1] NV Organon, Med Serv Womens Hlth, Urol, NL-5340 BH Oss, Netherlands
[2] Monash Univ, Alfred Hosp, Womens Hlth Program, Clayton, Vic 3168, Australia
[3] Univ Amsterdam, Acad Med Ctr, Dept Sexol & Psychosomat Obstet Gynecol, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Groningen Hosp, Dept Gynecol, Groningen, Netherlands
关键词
female sexual dysfunction; menopause; hormones; estrogens; testosterone; sildenafil; DHEAS; androgens;
D O I
10.1111/j.1743-6109.2006.00285.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction. A considerable number of double-blind randomized controlled studies investigating the effects of pharmaceutical intervention on female sexual functioning have been published in recent years. However, a comparison between outcomes of various studies is difficult as no generally accepted/correct approach to research has been established yet. To be able to translate trial results to daily clinical practice, current limitations and issues in drug intervention studies in female sexual dysfunction (FSD) need to be clarified. Aim. To evaluate the needs in research into intervention in FSD by reviewing published studies. Methods. A systematic review of double-blind randomized controlled intervention trials on FSD. Main Outcome Measures. Definitions of study populations, inclusion and exclusion criteria, use of power calculations, outcome measures and treatment duration. Results. A total of 25 double-blind randomized controlled trials investigating the effects of pharmaceutical intervention on female sexual functioning have been published. Of these, 11 studies required the diagnosis of FSD as an inclusion criterion. A standard methodology for research in this field is lacking. Significant differences in population inclusion requirements and tools for the measurement of change in sexual functioning were identified as major limiting factors. Conclusions. The investigation of FSD is an evolving area in that new definitions and a new model for female sexual functioning have been recently proposed. There is a need for experts in the field and regulating authorities to reach a consensus regarding appropriate inclusion and exclusion criteria for FSD trials and main outcome measures appropriate for the evaluation of drug interventions. This consensus should also determine which treatment effect is considered to be clinically relevant. Treatment efficacy and clinical relevance should be related to outcomes which are meaningful for affected women.
引用
收藏
页码:763 / 777
页数:15
相关论文
共 50 条
  • [31] Cardiometabolic Diseases and Female Sexual Dysfunction: Animal Studies
    Angulo, Javier
    Hannan, Johanna L.
    JOURNAL OF SEXUAL MEDICINE, 2022, 19 (03) : 408 - 420
  • [32] Assessment of female sexual dysfunction: review of validated methods
    Rosen, RC
    FERTILITY AND STERILITY, 2002, 77 (04) : S89 - S93
  • [33] Association between obesity and female sexual dysfunction: a review
    Saadedine, Mariam
    Faubion, Stephanie S.
    Grach, Stephanie L.
    Nordhues, Hannah C.
    Kapoor, Ekta
    SEXUAL MEDICINE REVIEWS, 2024, 12 (02) : 154 - 163
  • [34] Female hypoactive sexual desire. An offer of medical intervention
    Sanchez Sanchez, Froilan
    REVISTA INTERNACIONAL DE ANDROLOGIA, 2010, 8 (01): : 21 - 27
  • [35] Interactions of Sleep and Female Sexual Function: a Review
    Kling J.M.
    Kapoor E.
    Faubion S.S.
    Current Sexual Health Reports, 2018, 10 (4) : 339 - 344
  • [36] Female Sexual Dysfunction in Association with Sexual History, Sexual Abuse and Satisfaction: A Cross-Sectional Study in Hungary
    Erdos, Csaba
    Kelemen, Oguz
    Pocs, David
    Horvath, Edina
    Dudas, Nora
    Papp, Andras
    Paulik, Edit
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (03)
  • [37] The Correlation between Severity of Overactive Bladder Symptoms with Female Sexual Dysfunction and Sexual Satisfaction of Partners
    Wang, Yangyun
    Shi, Chaoliang
    Wang, Yang
    Jiao, Wei
    Wang, Xilong
    Zhang, Jun
    Shi, Guowei
    Wu, Denglong
    UROLOGIA INTERNATIONALIS, 2021, 105 (1-2) : 124 - 130
  • [38] Female Sexual Dysfunction, Sexual Distress, and Compatibility with Partner
    Witting, Katarina
    Santtila, Pekka
    Varjonen, Markus
    Jern, Patrick
    Johansson, Ada
    von der Pahlen, Bettina
    Sandnabba, Kenneth
    JOURNAL OF SEXUAL MEDICINE, 2008, 5 (11) : 2587 - 2599
  • [39] Female sexual dysfunction: A primary care perspective
    Zakhari, Raymond
    JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS, 2009, 21 (09): : 498 - 505
  • [40] Female sexual dysfunction: Definition, classification, and debates
    Chen, Ching-Hui
    Lin, Yen-Chin
    Chiu, Li-Hsuan
    Chu, Yuan-Hsiang
    Ruan, Fang-Fu
    Liu, Wei-Min
    Wang, Peng-Hui
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2013, 52 (01): : 3 - 7